Advertisement Celesio acquires stake in Brazilian pharma firm - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Celesio acquires stake in Brazilian pharma firm

Celesio, a German service provider for pharmaceutical and healthcare markets, has acquired 60% of Oncoprod Group, a Brazilian wholesaler for specialty pharmaceuticals.

The move in this direction has been made on the back of growing potential in the Brazilian pharma market.

Celesio CEO Markus Pinger said Brazil’s healthcare market grows above average, especially in the area of Specialty Pharmaceuticals and the acquisition is an optimal addition to Panpharma, their Brazilian wholesaler.

"With both companies we are focusing on our core competencies in pharmaceutical wholesale and distribution of specialty pharmaceuticals," Pinger added.